| 5466 |
Centers for Disease Control and Prevention |
Html |
en |
Propargyl alcohol - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 5837 |
Centers for Disease Control and Prevention |
Html |
en |
Nitrogen dioxide - NIOSH Pocket Guide to Chemical Hazards |
null |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 9598 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | The Massachusetts Emergency Medical Service Stroke Quality Improvement Collaborative, 2009"2012 - CDC |
Quality improvement collaboratives are a popular model used to address gaps between evidence-based practice and patient care. Little is known about use of such collaboratives in emergency medical services, particularly for improving prehospital stroke care. |
| acute stroke care | 0.552915 |
| stroke screening tools | 0.435766 |
| quality improvement collaboratives | 0.442373 |
| emergency stroke treatment | 0.449892 |
| timely stroke treatment | 0.428288 |
| recurrent stroke | 0.452001 |
| American Stroke Association | 0.43208 |
| Angeles Prehospital Stroke | 0.465399 |
| stroke quality improvement | 0.591215 |
| stroke mortality | 0.452176 |
| EMS Stroke Point | 0.587557 |
| process-based stroke performance | 0.489797 |
| Massachusetts EMS Stroke | 0.687204 |
| EMS agencies | 0.558431 |
| stroke screening | 0.481586 |
| internal stroke policies | 0.437728 |
| stroke mimics | 0.432249 |
| in-hospital stroke care | 0.512185 |
| Stroke Care Collaborative | 0.482923 |
| stroke systems | 0.444768 |
| stroke care data | 0.508731 |
| stroke care practices | 0.495133 |
| stroke recognition | 0.467857 |
| Association/American Stroke Association | 0.552905 |
| stroke patients | 0.522027 |
|
| high-quality stroke care | 0.50709 |
| Stroke Collaborative Reaching | 0.523295 |
| stroke alert policy | 0.434469 |
| Int J Stroke | 0.410575 |
| prehospital stroke care | 0.765643 |
| stroke performance measure | 0.478731 |
| emergency medical services | 0.732485 |
| stroke performance measures | 0.649101 |
| Heart Association/American Stroke | 0.552913 |
| acute stroke symptoms | 0.481067 |
| stroke prenotification | 0.462715 |
| stroke care | 0.963012 |
| Cincinnati Stroke Scale | 0.455866 |
| stroke QIC pilot | 0.536187 |
| prehospital stroke performance | 0.639814 |
| Stroke Prevention | 0.437056 |
| Stroke Association Expert | 0.425918 |
| stroke identification | 0.4177 |
| acute ischemic stroke | 0.558934 |
| EMS Stroke QIC | 0.728246 |
| et al | 0.440804 |
| Stroke Registry QIC | 0.522206 |
| stroke quality performance | 0.496497 |
| pilot EMS Stroke | 0.517672 |
|
CLICK HERE |
| 10156 |
Centers for Disease Control and Prevention |
Html |
en |
Arsenic - NIOSH Workplace Safety and Health Topic |
null |
| essential health | 0.241114 |
| Food Additive Series | 0.295858 |
| Occupational Exposure | 0.25859 |
| work environment | 0.23324 |
| NIOSH Criteria Document | 0.49782 |
| measurement methods | 0.235941 |
| Emergency Response Safety | 0.337476 |
| synonyms/trade names | 0.231409 |
| Health Topics | 0.2294 |
| high-priority chemical | 0.248327 |
| Arsenic Compounds | 0.660796 |
| Health Guideline | 0.233778 |
| NIOSH Manual | 0.378221 |
| Chemical Substance Information | 0.347074 |
| gallium arsenide | 0.361347 |
| concise information | 0.247513 |
| IARC Monographs | 0.334834 |
| Integrated Risk Information | 0.32249 |
| IDLH documents | 0.225975 |
| Intelligence Bulletin No. | 0.32153 |
| arsenic | 0.967415 |
| gallium arsenide dissociates | 0.360912 |
| Substance Data Bank | 0.300844 |
| information sources | 0.249659 |
| NIOSH Pocket Guide | 0.544957 |
|
| International Chemical Safety | 0.361398 |
| adverse effects | 0.304996 |
| respirator recommendations | 0.352608 |
| physical properties | 0.230782 |
| NIOSH Alert | 0.391566 |
| personal protection | 0.230611 |
| health concentrations | 0.326264 |
| Key data | 0.232819 |
| CAS/RTECS numbers | 0.231238 |
| safety information | 0.266504 |
| exposure limits | 0.372361 |
| conversion factors | 0.223469 |
| Chemical Sampling information | 0.340247 |
| Substances Disease Registry | 0.299096 |
| industrial hygiene information | 0.369435 |
| Health Database | 0.243849 |
| Recent experimental animal | 0.315265 |
| Publication No. | 0.43777 |
| emergency response community | 0.322015 |
| Environmental Health Criteria | 0.335002 |
| Substance Fact Sheets | 0.304907 |
| inorganic arsenic | 0.80845 |
| Hazardous Substance | 0.306492 |
| Risk Assessment Information | 0.325534 |
|
CLICK HERE |
| 10482 |
Centers for Disease Control and Prevention |
Html |
en |
Conference Call May 8, 2012'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 10516 |
Centers for Disease Control and Prevention |
Html |
en |
Email Updates: January 13, 2014'Clinicians Outreach and Communication Activity (COCA) |
CDC Clinician Outreach and Communication Activity (COCA). Providing clinicians the most current and reliable information on emerging public health threats, such as pandemics, natural disasters, and bioterrorism. |
| suspect malaria | 0.704114 |
| CDC | 0.999623 |
| avian influenza | 0.785619 |
| United States | 0.673289 |
| Emergency Preparedness | 0.662627 |
| COCA Email Update | 0.712068 |
| FDA Safety Information | 0.699302 |
| Salmonella Stanley Linked | 0.642301 |
| public health community | 0.692451 |
| U.S. Reach 40-Year | 0.686821 |
| – (CDC) | 0.750292 |
| new avian influenza | 0.713104 |
| CDC Science Clips | 0.84305 |
| human health information | 0.724611 |
| Additional COCA Conference | 0.693466 |
| CDC Influenza Division | 0.846275 |
| new H7N9 virus | 0.685532 |
| important safety information | 0.676835 |
| health care providers | 0.772017 |
| Weekly Flu View | 0.666319 |
| human medical products | 0.66281 |
| Free CE credit/contact | 0.659366 |
| Specific Hazards preparedness | 0.674402 |
| hazardous material incidents | 0.653921 |
|
| malaria prevention strategies | 0.786689 |
| ongoing malaria transmission | 0.772643 |
| Virus Infection Reported | 0.697473 |
| available immunization resources | 0.68372 |
| Current Travel Warnings | 0.652371 |
| Human Avian Influenza | 0.719452 |
| seasonal flu | 0.645133 |
| subject matter expert | 0.824201 |
| in-person training centers | 0.658264 |
| malaria cases | 0.851363 |
| recent ACIP recommendations | 0.695121 |
| FoodSafety.gov Reports FDA | 0.68066 |
| Event Reporting Program | 0.653457 |
| recent vaccine recommendations | 0.67222 |
| weekly influenza surveillance | 0.681769 |
| malaria infections | 0.705669 |
| substance identification support | 0.655973 |
| emergency responders | 0.661345 |
| FDA Investigates Outbreak | 0.673584 |
| USDA Food Recalls | 0.654119 |
| Response Training Resources | 0.670618 |
| CDC subject matter | 0.997976 |
| confirmed malaria cases | 0.792001 |
|
CLICK HERE |
| 12153 |
Centers for Disease Control and Prevention |
Html |
en |
Diphtheria | Laboratory | Specimen Collection | CDC |
CDC’s Pertussis and Diphtheria Laboratory provides laboratory support to US health departments requesting assistance with isolation, identification, and sub-typing of Corynebacterium diphtheriae... |
| hospital personnel | 0.308599 |
| Diphtheria Laboratory | 0.797096 |
| B. parapertussis | 0.316429 |
| list Skip | 0.645254 |
| page options Skip | 0.937595 |
| Bordetella pertussis | 0.655266 |
| outbreak support | 0.331789 |
| Corynebacterium diphtheriae | 0.377548 |
| navigation Skip | 0.645275 |
| laboratory resources | 0.300494 |
|
| CDC’s Pertussis | 0.634143 |
| B. holmesii | 0.315782 |
| diphtheria specimen collection | 0.804181 |
| U.S. health departments | 0.610287 |
| international researchers | 0.310112 |
| health departments | 0.630334 |
| C. ulcerans | 0.38734 |
| laboratory support | 0.326071 |
| local health departments | 0.582167 |
| serologic methods | 0.296695 |
|
CLICK HERE |
| 12943 |
Centers for Disease Control and Prevention |
Html |
en |
Measles | Cases and Outbreaks | CDC |
null |
| generalized maculopapular rash… | 0.375129 |
| CDC’s National | 0.347698 |
| unvaccinated Amish communities | 0.378963 |
| measles elimination | 0.589489 |
| outbreak investigation | 0.410338 |
| Casos y brotes | 0.349206 |
| Measles Outbreak | 0.620052 |
| large outbreaks | 0.350556 |
| measles outbreaks | 0.572983 |
| Shelby County | 0.370217 |
| Customs Enforcement | 0.373083 |
| additional information | 0.342531 |
| Associated International Traveler | 0.371444 |
| MMWR. Sep | 0.411506 |
| large measles | 0.58251 |
| California | 0.347553 |
| measles virus type | 0.599888 |
| United States Immigration | 0.387325 |
| MMWR. Vol | 0.370143 |
| Respiratory Diseases | 0.347056 |
| multi-state measles | 0.569869 |
| high vaccination coverage | 0.375744 |
| record number | 0.347253 |
| ongoing outbreak | 0.400184 |
|
| United States | 0.780825 |
| MMWR. Feb | 0.346081 |
| Surveillance Manual chapter | 0.375626 |
| ongoing measles | 0.539603 |
| measles cases | 0.792359 |
| U.S. | 0.390439 |
| U.S. residents | 0.343644 |
| New York | 0.386556 |
| positive measles | 0.547347 |
| MMWR. Apr | 0.344461 |
| CDC scientists | 0.34385 |
| U.S. Immigration | 0.343945 |
| European Region | 0.343263 |
| unvaccinated people | 0.344833 |
| people | 0.365351 |
| local public health | 0.372851 |
| New Jersey | 0.347817 |
| large outbreak | 0.450494 |
| Orange County | 0.406884 |
| amusement park | 0.388359 |
| Disney theme parks | 0.369972 |
| measles | 0.958548 |
| greatest number | 0.34523 |
| outbreak control | 0.411361 |
|
CLICK HERE |
| 15366 |
Centers for Disease Control and Prevention |
Html |
en |
Self-Reported Sitting Time in New York City Adults, The Physical Activity and Transit Survey, 2010-2011 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| 2-question method | 0.417648 |
| demographic characteristics | 0.359657 |
| accelerometer participants | 0.356019 |
| poverty status | 0.358252 |
| questions | 0.361413 |
| Research Triangle Institute | 0.360683 |
| AMA PRA | 0.386124 |
| distinct sedentary behavior | 0.400761 |
| New York City | 0.482566 |
| sedentary time | 0.815831 |
| health outcomes | 0.392448 |
| accelerometer-reported sitting time | 0.501343 |
| self-reported sitting time | 0.956224 |
| daily sitting time | 0.490522 |
| population surveillance | 0.364326 |
| PA levels | 0.368704 |
| accelerometer wear time | 0.410765 |
| lower education levels | 0.372126 |
| accelerometer-measured sedentary time | 0.671556 |
| recreational time | 0.362746 |
| life expectancy | 0.379109 |
| nonrecreational physical activity | 0.374726 |
| specific sedentary behavior | 0.429046 |
| high sitting times | 0.442046 |
|
| New York University | 0.360524 |
| C. Sitting | 0.423006 |
| AMA PRA Category | 0.367578 |
| Journal-based CME activity | 0.354288 |
| higher mean duration | 0.369028 |
| Evening Sitting Times | 0.438301 |
| accelerometer data | 0.493403 |
| higher education levels | 0.384743 |
| self-reported data | 0.380527 |
| lipoprotein lipase activity | 0.375292 |
| sedentary activity | 0.386705 |
| sedentary behavior | 0.496584 |
| York City Health | 0.358008 |
| multiple sedentary behaviors | 0.395078 |
| accelerometer-assessed sedentary time | 0.546388 |
| physical activity | 0.448642 |
| higher levels | 0.361007 |
| self-report data | 0.355545 |
| self-reported sedentary time | 0.493049 |
| PAT Survey | 0.400832 |
| York City Department | 0.365595 |
| B. Sitting | 0.423109 |
| NYC Health Department | 0.441055 |
| mean difference | 0.416468 |
|
CLICK HERE |
| 15669 |
Centers for Disease Control and Prevention |
Html |
en |
Contraceptive Use Among Nonpregnant and Postpartum Women atRisk for Unintended Pregnancy, and Female High School Students, inthe Context of Zika Preparedness - United States, 2011-2013 and2015 | MMWR |
The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC). |
| effective contraceptive methods | 0.750159 |
| Zika virus | 0.835512 |
| effective contraception | 0.506504 |
| transdermal contraceptive patch | 0.61355 |
| fertility-based awareness methods | 0.565936 |
| nonpermanent contraceptive methods | 0.626333 |
| contraceptive pills | 0.696073 |
| ongoing contraceptive services.§§§ | 0.579822 |
| unintended pregnancy | 0.944852 |
| contraceptive method options | 0.614244 |
| FDA-approved contraceptive methods | 0.590648 |
| contraceptive method availability | 0.5789 |
| sexually active female | 0.685545 |
| contraception | 0.62677 |
| LARC methods | 0.553848 |
| §§Moderately effective contraceptive | 0.580373 |
| permanent contraception | 0.52963 |
| oral contraceptive pills | 0.626729 |
| Moderately effective contraceptive | 0.602042 |
| Zika virus transmission | 0.517344 |
| contraceptive methods | 0.949098 |
| emergency contraception | 0.517166 |
| women | 0.64005 |
| effective contraceptive option | 0.622907 |
| contraceptive use profile | 0.550865 |
|
| LARC | 0.661465 |
| age group | 0.52023 |
| contraceptive care | 0.565317 |
| Zika virus infection | 0.634041 |
| states | 0.49232 |
| female high school | 0.734012 |
| small sample sizes | 0.497815 |
| postpartum women | 0.497436 |
| long-acting reversible contraception | 0.572643 |
| contraceptive need | 0.555834 |
| live birth | 0.515282 |
| permanent contraceptive methods | 0.655692 |
| intrauterine devices | 0.527499 |
| effective reversible method | 0.494093 |
| transdermal contraceptive patches | 0.584914 |
| **Moderately effective contraceptive | 0.576352 |
| §Moderately effective contraceptive | 0.583229 |
| high school students | 0.740361 |
| contraceptive services | 0.611906 |
| reversible contraception | 0.599966 |
| Aedes albopictus mosquitoes | 0.50783 |
| high device costs | 0.508842 |
| contraceptive implants | 0.557815 |
| risk | 0.492316 |
|
CLICK HERE |